发明名称 Methods of intravenous administration of glyburide and other drugs
摘要 Methods of administering glyburide, or other drug, are disclosed. The novel methods disclosed herein include intravenous methods of administering glyburide, or other drug, over periods of more than an hour, preferably over periods of about 72 hours. The novel methods include administering a bolus of glyburide, or other drug, followed by a first continuous infusion administration of glyburide, or other drug; and optionally a second or further bolus administration of glyburide, or other drug, and/or a second or further continuous infusion administration of glyburide, or other drug. These methods are effective to rapidly achieve a desired level of glyburide, or other drug, and to provide a substantially steady level of glyburide, or other drug, over a desired period of time. The methods disclosed herein may be useful for treating a subject in need of treatment for, e.g., acute stroke (ischemic and hemorrhagic), traumatic brain injury (TBI), spinal cord injury (SCI), myocardial infarction (MI), shock (including hemorrhagic shock), organ ischemia, and ventricular arrhythmias. These methods provide for the rapid achievement and maintenance of therapeutic glyburide, or other drug, plasma levels over an extended period of time, and further avoid excessive levels of drug and so avoid possible drug side-effects.
申请公布号 US8946293(B2) 申请公布日期 2015.02.03
申请号 US201113811037 申请日期 2011.07.18
申请人 Remedy Pharmaceuticals, Inc. 发明人 Jacobson Sven Martin
分类号 A61K31/175;A01N47/34;A61K31/18;A61K31/64 主分类号 A61K31/175
代理机构 Thorpe North & Western LLP 代理人 Thorpe North & Western LLP
主权项 1. A method of treating acute stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, hypoxia/ischemia, or other injuries, conditions, and disorders, in a subject in need of treatment, comprising administration of a first bolus and a second bolus of glyburide followed by a continuous infusion of glyburide to a subject in need of treatment, said administration comprising: (a) a first bolus administration of glyburide; (b) a second bolus administration of glyburide, after said first bolus, and (c) a first continuous infusion administration of glyburide after said second bolus administration of glyburide effective to provide a substantially steady level of glyburide in the blood of said subject over a desired period of time.
地址 New York NY US